MEDICON VILLAGE, LUND, SWEDEN – Karger Publishers is a worldwide academic publisher of scientific and medical content. Advancing the future of science, Karger Publishers launched the Annual Vesalius Award, offering great exposure to the finalists and the possibility to bring their ideas to the next level and be part of the scientific revolution.
All five finalists will benefit from mentoring by experienced experts and will have the opportunity to participate in the live pitching event and award ceremony at the STM Innovations Day 2023, held at BMA House, British Medical Association, London. The overall winner and two runners-up will receive a financial prize to support future expansion.
“We are thrilled and deeply honored to receive this recognition from Karger. Their focus on Health Sciences for 2023, with main topics such as Artificial Intelligence and Patient Centricity, both of which are core foundations of Paindrainer®, is a strong indicator that we have a cutting-edge solution with enormous potential to shape the future of chronic pain management.”, says Erik Frick, CEO of Paindrainer AB.
Surgeon Andreas Vesalius, the inspiration behind Karger’s annual innovation award, not only revolutionized anatomy when he published “De humanis corporis fabrica” in 1543. His work also took typography and illustration to a new level, laying the foundation for an entirely new view on the human body for many generations.
For more information, please contact:
VD Paindrainer AB
+46 736 612123
About Paindrainer AB
Paindrainer AB is a company developing digital platforms and applications contributing to health and well-being. Paindrainer was founded in 2018 by Prof. Carl Borrebaeck, Dr. Maria Rosén Klement, and Göran Barkfors. The idea was born when Maria, after participating in several pain rehabilitation programs, realized that the pain is affected by many more factors than the human brain can comprehend.
Paindrainer® is the first evidence-based AI powered digital tool demonstrating improved quality of life in patients suffering from chronic pain.
Paindrainer® coaches the users in managing their pain and planning their day not to exceed a certain pain level, and to ensure that there is enough energy left for highly valued activities. The solution is powered by leveraging advanced algorithms and is fully adaptive to each patient, a feature called 360o patient-centricity©.
Paindrainer® (Paindrainer PD1) is an FDA registered Medical Device Class 1 (510k exemption), MDR compliant and CE certified.